These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35178611)

  • 1. Integrase Inhibitors are Associated with Neuropsychiatric Symptoms in Women with HIV.
    Rubin LH; O'Halloran JA; Williams DW; Li Y; Fitzgerald KC; Dastgheyb R; Damron AL; Maki PM; Spence AB; Sharma A; Gustafson DR; Milam J; Weber KM; Adimora AA; Ofotokun I; Fischl MA; Konkle-Parker D; Xu Y
    J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):1-8. PubMed ID: 35178611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Starting or Switching to an Integrase Inhibitor-Based Regimen Affects PTSD Symptoms in Women with HIV.
    Kamkwalala AR; Wang K; O'Halloran J; Williams DW; Dastgheyb R; Fitzgerald KC; Spence AB; Maki PM; Gustafson DR; Milam J; Sharma A; Weber KM; Adimora AA; Ofotokun I; Sheth AN; Lahiri CD; Fischl MA; Konkle-Parker D; Xu Y; Rubin LH
    AIDS Behav; 2021 Jan; 25(1):225-236. PubMed ID: 32638219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrase Strand Transfer Inhibitor Start or Switch Impacts Learning in Women With HIV.
    O'Halloran JA; Wang K; Spence AB; Williams DW; Dastgheyb R; Fitzgerald KC; Kamkwalala AR; Maki PM; Sharma A; Gustafson DR; Milam J; Weber KM; Adimora AA; Ofotokun I; Fischl MA; Konkle-Parker D; Lahiri CD; Sheth AN; Xu Y; Rubin LH
    J Acquir Immune Defic Syndr; 2021 Apr; 86(5):593-599. PubMed ID: 33394812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between Antiretrovirals and Cognitive Function in Women with HIV.
    Rubin LH; Li Y; Fitzgerald KC; Dastgheyb R; Spence AB; Maki PM; Sharma A; Gustafson DR; Milam J; Weber KM; Adimora AA; Haughey NJ; Ofotokun I; Fischl MA; Konkle-Parker D; Xu Y; Williams DW
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):195-206. PubMed ID: 32212091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions to integrase strand transfer inhibitors.
    Lepik KJ; Yip B; Ulloa AC; Wang L; Toy J; Akagi L; Lima VD; Guillemi S; Montaner JSG; Barrios R
    AIDS; 2018 Apr; 32(7):903-912. PubMed ID: 29424784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between Antiretroviral Drugs on Depressive Symptomatology in Homogenous Subgroups of Women with HIV.
    Williams DW; Li Y; Dastgheyb R; Fitzgerald KC; Maki PM; Spence AB; Gustafson DR; Milam J; Sharma A; Adimora AA; Ofotokun I; Fischl MA; Konkle-Parker D; Weber KM; Xu Y; Rubin LH
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):181-194. PubMed ID: 31933016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting.
    d'Arminio Monforte A; Cozzi-Lepri A; Di Biagio A; Marchetti G; Lo Caputo S; Rusconi S; Gianotti N; Mazzotta V; Mazzarello G; Costantini A; Castagna A; Antinori A;
    J Antimicrob Chemother; 2019 May; 74(5):1363-1367. PubMed ID: 30698801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort.
    Cuzin L; Pugliese P; Katlama C; Bani-Sadr F; Ferry T; Rey D; Lourenco J; Bregigeon S; Allavena C; Reynes J; Cabié A;
    J Antimicrob Chemother; 2019 Mar; 74(3):754-760. PubMed ID: 30534993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients.
    Fourati S; Charpentier C; Amiel C; Morand-Joubert L; Reigadas S; Trabaud MA; Delaugerre C; Nicot F; Rodallec A; Maillard A; Mirand A; Jeulin H; Montès B; Barin F; Bettinger D; Le Guillou-Guillemette H; Vallet S; Signori-Schmuck A; Descamps D; Calvez V; Flandre P; Marcelin AG;
    J Antimicrob Chemother; 2015 May; 70(5):1507-12. PubMed ID: 25558077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degree of Polypharmacy and Cognitive Function in Older Women with HIV.
    Rubin LH; Neijna AG; Shi Q; Hoover DR; Tamraz B; Anastos K; Edmonds A; Fischl MA; Gustafson D; Maki PM; Merenstein D; Sheth AN; Springer G; Vance D; Weber KM; Sharma A
    AIDS Res Hum Retroviruses; 2022 Jul; 38(7):571-579. PubMed ID: 35357949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability of integrase inhibitors in a real-life setting.
    Peñafiel J; de Lazzari E; Padilla M; Rojas J; Gonzalez-Cordon A; Blanco JL; Blanch J; Marcos MA; Lonca M; Martinez-Rebollar M; Laguno M; Tricas A; Rodriguez A; Mallolas J; Gatell JM; Martinez E
    J Antimicrob Chemother; 2017 Jun; 72(6):1752-1759. PubMed ID: 28333231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability of HIV integrase inhibitors.
    Lee FJ; Carr A
    Curr Opin HIV AIDS; 2012 Sep; 7(5):422-8. PubMed ID: 22886031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.
    João EC; Morrison RL; Shapiro DE; Chakhtoura N; Gouvèa MIS; de Lourdes B Teixeira M; Fuller TL; Mmbaga BT; Ngocho JS; Njau BN; Violari A; Mathiba R; Essack Z; Pilotto JHS; Moreira LF; Rolon MJ; Cahn P; Prommas S; Cressey TR; Chokephaibulkit K; Werarak P; Laimon L; Hennessy R; Frenkel LM; Anthony P; Best BM; Siberry GK; Mirochnick M
    Lancet HIV; 2020 May; 7(5):e322-e331. PubMed ID: 32386720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell activation state differentially contributes to neuropsychiatric complications in women with HIV.
    Williams DW; Flores BR; Xu Y; Wang Y; Yu D; Peters BA; Adedimeji A; Wilson TE; Merenstein D; Tien PC; Cohen MH; Weber KM; Adimora AA; Ofotokun I; Fischl M; Turan J; Turan B; Laumet G; Landay AL; Dastgheyb RM; Gange SJ; Weiser SD; Rubin LH
    Brain Behav Immun Health; 2022 Nov; 25():100498. PubMed ID: 36097532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda.
    Ndashimye E; Avino M; Olabode AS; Poon AFY; Gibson RM; Li Y; Meadows A; Tan C; Reyes PS; Kityo CM; Kyeyune F; Nankya I; Quiñones-Mateu ME; Arts EJ
    J Antimicrob Chemother; 2020 Dec; 75(12):3525-3533. PubMed ID: 32853364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of birth defects and perinatal outcomes in HIV-infected women exposed to integrase strand inhibitors during pregnancy.
    Sibiude J; Le Chenadec J; Mandelbrot L; Dollfus C; Matheron S; Lelong N; Avettand-Fenoel V; Brossard M; Frange P; Reliquet V; Warszawski J; Tubiana R;
    AIDS; 2021 Feb; 35(2):219-226. PubMed ID: 33048878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients.
    Brehm TT; Franz M; Hüfner A; Hertling S; Schmiedel S; Degen O; Kreuels B; Schulze Zur Wiesch J
    Medicine (Baltimore); 2019 Aug; 98(32):e16721. PubMed ID: 31393378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors.
    Malet I; Subra F; Charpentier C; Collin G; Descamps D; Calvez V; Marcelin AG; Delelis O
    mBio; 2017 Sep; 8(5):. PubMed ID: 28951475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients.
    Hoffmann C; Welz T; Sabranski M; Kolb M; Wolf E; Stellbrink HJ; Wyen C
    HIV Med; 2017 Jan; 18(1):56-63. PubMed ID: 27860104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Combination of the R263K and T66I Resistance Substitutions in HIV-1 Integrase Is Incompatible with High-Level Viral Replication and the Development of High-Level Drug Resistance.
    Liang J; Mesplède T; Oliveira M; Anstett K; Wainberg MA
    J Virol; 2015 Nov; 89(22):11269-74. PubMed ID: 26311878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.